Within the mice administered free aPD-1, only 17.1% of the tumor-infiltrating CD8 + T cells were obstructed by aPD-1 (identified as APC-Cy7 positive), whereas the APC-Cy7-positive cell population escalated to 54.3% in mice subjected to nanodrug treatment. The gene discussed is CD8A; the disease is neoplasm.